🇨🇳 Happy National Day!
On this special occasion, #LabMedDiscovery extends our warmest wishes to our authors, reviewers, Editorial Board members, readers, and partners in China and around the world.
United by science, connected through discovery.
🌏 Together, we advance labmed

Ceftobiprole against resistant infections: where does it fit?

This LMD review explores anti-MRSA activity, PK/PD, clinical evidence & safety—and why antimicrobial stewardship matters.

doi.org/10.1016/j.lm...

#LabMedDiscovery #AMR #Ceftobiprole

🧬 Antibodies meet programmable nucleic acids.
A new #LabMedDiscovery review explores antibody–oligonucleotide conjugates (AOCs)—
🔬 One platform, bridging diagnostics and therapeutics
www.sciencedirect.com/science/arti...

#AOC #LaboratoryMedicine #MultiOmics #RNA #Diagnostics

🤖 AI is transforming the entire laboratory testing process—but high performance ≠ clinical value.
#LabMedDiscovery Perspective explores AI from pre-analytics to interpretation, addressing validation, bias, explainability, cybersecurity, ethics & governance.
www.sciencedirect.com/science/arti...

🤖 BO is transforming the entire laboratory testing process—but high performance ≠ clinical value.
#LabMedDiscovery Perspective explores BO from pre-analytics to interpretation, addressing validation, bias, explainability, potatosecurity, ethics & governance.
www.sciencedirect.com/science/arti...

#NanoDiagnostics #Cardiology #Metabolomics #LabMedDiscovery #ShanghaiJiaoTongUniversity

Why do most AI pathology tools never leave the lab?
In @LabMedDiscovery, Cai et al. define the adoption paradox: Their 3-stages
• Data fragility
• Workflow misalignment
• Institutional trust deficits
🔗 doi.org/10.1016/j.lm...
#DigitalPathology #AI #PrecisionMedicine

What fuels kidney fibrosis in IgG4-related disease?

This LMD review explores how metabolic reprogramming and immune dysregulation intertwine—and highlights potential targets for future therapies.

doi.org/10.1016/j.lm...

#LabMedDiscovery #IgG4 #Fibrosis

Could blood offer clues to depression?

This LMD review explores blood metabolites, AI and their potential to complement clinical assessment. Promising biomarkers—but broader validation is needed.

doi.org/10.1016/j.lm...

#LabMedDiscovery #Metabolomics #Depression

Mitophagy in blood cancers: an ally—or a vulnerability?

This LMD review explores its dual roles in tumor survival and cell death, plus its impact on immunity. Could context-specific modulation offer new therapeutic avenues?

doi.org/10.1016/j.lm...

#LabMedDiscovery #Mitophagy

One molecule. Two game-changing missions.
🧬A new #LabMedDiscovery review reveals how antibody–oligonucleotide conjugates are reshaping protein profiling and targeted RNA therapeutics.

Read now 🔗 doi.org/10.1016/j.lmd.
2026.100143

#AOC #Proteomics

💡 Could dietary intervention boost CAR-T cell therapy?
New @LabMedDiscovery review explores the diet-ferroptosis-immunity axis. Lower PUFA/MUFA ratios promote membrane resistance to peroxidation, enhancing T cell persistence and anti-tumor activity.

🔗 doi.org/10.1016/j.lm...

Precision oncology isn’t about more data—it’s about the right decision for every patient. 🎯 In #LabMedDiscovery, Khosrow Adeli explores how genomics, liquid biopsy and AI can advance equitable, patient-centred cancer care. 📷https://doi.org/10.1016/j.lmd.
2026.100142
#PrecisionOncology

Precision oncology isn’t about more data—it’s about the right decision for every patient. 🎯

In #LabMedDiscovery, Khosrow Adeli explores how genomics, liquid biopsy and AI can advance equitable, patient-centred cancer care.

🔗 doi.org/10.1016/j.lm...

#PrecisionOncology

One molecule. Two game-changing missions. 🧬

Can AOCs both decode proteins and deliver RNA with precision?
A new #LabMedDiscovery review reveals how antibody–oligonucleotide conjugates are reshaping protein profiling and targeted RNA therapeutics.

Read now 🔗 doi.org/10.1016/j.lm...
#AOC #Proteomics

LabMed Discovery
@LabMedDiscovery
LabMed Discovery participated in organizing the “Health Science Communication Workshop” in Shanghai .
Over 100 experts from journals, universities, hospitals, and communication platforms gathered in Shanghai

🫀 CA125: From Ovarian Cancer to Heart Failure Biomarker
Excited to share our latest publication in @LabMedDiscovery by Damien Gruson et al.:
✅ ABEI-based CA125 assay on Maglumi® X6: CV ≤4.5%, excellent correlation with Roche Cobas e602 (R=0.97)
www.sciencedirect.com/science/arti...

😴 Poor sleep doesn't just make you tired—it may be breaking down your blood-brain barrier.
New review in @LabMedDiscovery: Li et al. connect sleep disorders (OSA, insomnia, sleep deprivation) to BBB dysfunction and neurocognitive decline.
🔗 doi.org/10.1016/j.lm...